Cancel
Enveda
Enveda Employees
17 people indexed:
-
71hwxj.xz95k@z77w237yj.6r9 Sign up to see email
-
zlt91.t306h1@34fzt9lkk.036 Sign up to see email
-
z01.ytp@gpf5g2hh7.0ut Sign up to see email
-
zs9xr.w009pu@z8qfpsf6g.wqt Sign up to see email
-
Eswar Sunil Kumar Bonangi
Vice President, Head of India Operations
4pq63.hqzfz.yz2qq.4j5f5fq@jp913jp2f.xt6 Sign up to see email980tq.hhqhj.3y97f.pp0839q@932hpy95h.t37 Sign up to see email -
2ftu79.3571yy@tpq813ks2.7q3 Sign up to see email
-
Jason Tejani
Senior Vice President, Legal, Intellectual Property
31u61.xly62g@3868wlkxg.621 Sign up to see emailpuy8u.l4w0zu@rguwgx2wu.x59 Sign up to see email -
2ys.yz7pz8z@zss3uh05u.190 Sign up to see email
-
zufyly.ypxp6p6z5@0f31f76l9.68f Sign up to see email
-
zp3xkz.02@ww1h9hs59.jkj Sign up to see email
-
2ff3kh2.0q9zp@jj0z75swh.7x9 Sign up to see email
-
Pieter Dorrestein, Ph.D.
Scientific Co-Founder & SAB Chair | UC San Diego
u68q50.2jz2q4x44q.86.8@jxkfyx74k.y8l Sign up to see emailgy9jf1.kk273x4x5f.y7.j@45w0gj6ug.0xj Sign up to see email -
9x.yyx381@214s1qt6r.yf4 Sign up to see email
-
3377h6.3s128q0@p3580819w.w02 Sign up to see email
-
7qfgu372.1u47yl50ff5zf@fwpxlf062.733 Sign up to see email
-
Soumoditya Dey
Vice President, Corporate Development
gr1kxzwhhk.9xf@31gp3h4ww.f8z Sign up to see emailg1jq292746.kql@98k6p172f.41f Sign up to see email -
6jh2k.g02x4y7@3j317y6tt.39x Sign up to see email
Enveda Company Information
Enveda is a pioneering company that leverages advanced technologies such as machine learning, metabolomics, and robotics to explore and utilize nature’s vast chemical diversity for new drug discovery. The company has developed a unique platform that significantly improves the speed and scale at which new medicines are discovered from natural sources. Enveda operates high-throughput experiments, creating the world’s most diverse biologically annotated dataset of small molecules. With a strategic aim to transform human health, Enveda focuses on mapping and discovering potent and impactful medicines derived from nature’s chemistry. The company’s innovative MS2Mol algorithm plays a crucial role in decoding nature’s chemical language, thereby enhancing the efficiency of drug discovery. Enveda is headquartered in Boulder, Colorado, with additional offices in Hyderabad, India. It has successfully raised $68 million in a combined Series B equity and debt financing round and later announced an oversubscribed Series B1 round, bringing its total funding to $119 million. Furthermore, Enveda hosts the world’s largest computable database of ethnobotany, which includes information on 38,000 plants and 11,000 diseases, supporting its research and development efforts in creating new medicinal solutions.
Report inaccurate information
Report inaccurate information
